Cognex (CGNX) Shareholder Brown Capital Management Has Raised Its Position by $6.85 Million as Share Price Declined; Suffolk Capital Management Lifted Its Sage Theraputics (SAGE) Position by $2.47 Million as Market Valuation Declined

Cognex Corporation (NASDAQ:CGNX) Logo

Brown Capital Management Llc increased its stake in Cognex Corp (CGNX) by 1.29% based on its latest 2018Q3 regulatory filing with the SEC. Brown Capital Management Llc bought 124,571 shares as the company’s stock declined 23.90% with the market. The institutional investor held 9.76M shares of the industrial machinery and components company at the end of 2018Q3, valued at $544.55M, up from 9.63M at the end of the previous reported quarter. Brown Capital Management Llc who had been investing in Cognex Corp for a number of months, seems to be bullish on the $7.19 billion market cap company. The stock decreased 0.88% or $0.37 during the last trading session, reaching $41.74. About 632,961 shares traded. Cognex Corporation (NASDAQ:CGNX) has declined 34.58% since January 12, 2018 and is downtrending. It has underperformed by 34.58% the S&P500. Some Historical CGNX News: 30/04/2018 – Cognex Declares Quarterly Cash Dividend; 03/05/2018 – Cognex to Webcast Conference Presentations; 30/04/2018 – COGNEX 1Q ADJ. EPS 18C; 30/04/2018 – COGNEX 1Q EPS 21C; 01/05/2018 – Analyst Neil Campling of Mirabaud Securities said that weaker-than-expected first quarter earnings and second quarter earnings from Cognex provide more evidence of this; 10/05/2018 – lvanti Introduces Support for Cognex Mobile Data Capture Solutions; 07/05/2018 – Cognex Presenting at Conference Jun 6

Suffolk Capital Management Llc increased its stake in Sage Theraputics Inc (SAGE) by 23.24% based on its latest 2018Q3 regulatory filing with the SEC. Suffolk Capital Management Llc bought 17,536 shares as the company’s stock declined 33.17% with the market. The institutional investor held 93,000 shares of the health care company at the end of 2018Q3, valued at $13.14 million, up from 75,464 at the end of the previous reported quarter. Suffolk Capital Management Llc who had been investing in Sage Theraputics Inc for a number of months, seems to be bullish on the $5.87B market cap company. The stock decreased 0.89% or $1.12 during the last trading session, reaching $125.1. About 449,131 shares traded. Sage Therapeutics, Inc. (NASDAQ:SAGE) has risen 17.03% since January 12, 2018 and is uptrending. It has outperformed by 17.03% the S&P500. Some Historical SAGE News: 10/04/2018 – SAGE CANCELS DUE TO SOME TRAVEL LOGISTICS ISSUES; 09/05/2018 – Sage lntacct Named 2018 Top Rated Enterprise Resource Planning Solution by TrustRadius; 13/04/2018 – Britain’s FTSE under pressure as Sage sinks; 13/04/2018 – Sage Group: 1H Organic Revenue Growth 6.3%; 02/05/2018 – Sage Group 1H Pre-items, Pretax Pft GBP208M; 19/03/2018 – SAGE INTERNATIONAL GROUP LTD – CHUI BING SUN RESIGNED AS EXECUTIVE DIRECTOR AND CHAIRMAN; 12/03/2018 – Goodway Group Select Sage lntacct to Manage its Digital Evolution Realizing 227% Growth; 16/03/2018 – HK Bourse: Announcement From Century Sage Scientific Holdings Ltd; 30/05/2018 – Sage Therapeutics: Priority Review Status Expected to Accelerate Review Period; 25/04/2018 – Vena Adds FP&A Integration to Sage Intacct’s Cloud Financial Management System

Investors sentiment decreased to 1.15 in Q3 2018. Its down 0.56, from 1.71 in 2018Q2. It fall, as 23 investors sold SAGE shares while 73 reduced holdings. 43 funds opened positions while 67 raised stakes. 46.64 million shares or 0.64% less from 46.94 million shares in 2018Q2 were reported. Quantbot Technology LP has 0% invested in Sage Therapeutics, Inc. (NASDAQ:SAGE). Schwab Charles Inv Mngmt Inc invested in 177,551 shares or 0.02% of the stock. Renaissance Techs Lc accumulated 2,800 shares. 230 are held by Daiwa Secs Gru. Goldman Sachs Incorporated reported 224,143 shares. Cwm Limited Liability Corporation stated it has 6 shares. Stevens Cap Limited Partnership has 26,177 shares. State Of Wisconsin Board has invested 0% in Sage Therapeutics, Inc. (NASDAQ:SAGE). Trellus Mngmt Limited Liability Corp stated it has 0.35% of its portfolio in Sage Therapeutics, Inc. (NASDAQ:SAGE). 95,165 were accumulated by Morgan Stanley. Susquehanna Interest Ltd Liability Partnership holds 0.01% in Sage Therapeutics, Inc. (NASDAQ:SAGE) or 144,352 shares. Zacks Inv accumulated 4,871 shares or 0.01% of the stock. Great West Life Assurance Communication Can reported 5,186 shares stake. 391,548 were reported by Pictet Asset Management Ltd. Loring Wolcott And Coolidge Fiduciary Advsr Llp Ma owns 50 shares.

Among 20 analysts covering SAGE Therapeutics (NASDAQ:SAGE), 17 have Buy rating, 1 Sell and 2 Hold. Therefore 85% are positive. SAGE Therapeutics had 66 analyst reports since September 3, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Thursday, December 7 by BMO Capital Markets. On Tuesday, February 27 the stock rating was maintained by SunTrust with “Buy”. Leerink Swann maintained Sage Therapeutics, Inc. (NASDAQ:SAGE) on Thursday, December 7 with “Buy” rating. H.C. Wainwright downgraded it to “Neutral” rating and $76 target in Wednesday, February 22 report. The firm has “Overweight” rating by Morgan Stanley given on Friday, July 13. The rating was maintained by SunTrust with “Buy” on Thursday, December 7. BMO Capital Markets initiated the stock with “Outperform” rating in Wednesday, June 29 report. On Tuesday, September 12 the stock rating was maintained by Canaccord Genuity with “Buy”. RBC Capital Markets maintained Sage Therapeutics, Inc. (NASDAQ:SAGE) rating on Monday, October 16. RBC Capital Markets has “Buy” rating and $117.0 target. The rating was upgraded by Chardan Capital Markets on Tuesday, May 22 to “Buy”.

Suffolk Capital Management Llc, which manages about $1.92B and $702.74 million US Long portfolio, decreased its stake in Wal (NYSE:WMT) by 148,691 shares to 3,135 shares, valued at $294,000 in 2018Q3, according to the filing. It also reduced its holding in Nomad Foods Ltd by 20,004 shares in the quarter, leaving it with 26,506 shares, and cut its stake in Nvidia Corp. (NASDAQ:NVDA).

More notable recent Sage Therapeutics, Inc. (NASDAQ:SAGE) news were published by: Seekingalpha.com which released: “Key events next week – healthcare – Seeking Alpha” on December 14, 2018, also Fool.com with their article: “3 Biggest Stories at the J.P. Morgan Healthcare Conference This Year – Motley Fool” published on January 10, 2019, Businesswire.com published: “Sage Therapeutics to Provide Pipeline Update at J.P. Morgan Healthcare Conference and Outline Key 2018 Initiatives to Support Planned Evolution to a Fully-Integrated Commercial Biopharmaceutical Company – Business Wire” on January 08, 2018. More interesting news about Sage Therapeutics, Inc. (NASDAQ:SAGE) were released by: Finance.Yahoo.com and their article: “The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial – Yahoo! Finance News” published on December 21, 2018 as well as Nasdaq.com‘s news article titled: “SAGE Therapeutics Inc. (SAGE) Is Up Sharply On Study Results – Nasdaq” with publication date: January 07, 2019.

More notable recent Cognex Corporation (NASDAQ:CGNX) news were published by: Finance.Yahoo.com which released: “Barron’s Picks And Pans: Coca-Cola, Disney, McDonald’s, Verizon And More – Yahoo Finance” on December 29, 2018, also Nasdaq.com with their article: “Cognex (CGNX) Q3 Earnings Preview: What’s in the Cards? – Nasdaq” published on October 22, 2018, Investorplace.com published: “15 Winning Stocks to Buy in 2019 (That Were Losers in 2018) – Investorplace.com” on December 14, 2018. More interesting news about Cognex Corporation (NASDAQ:CGNX) were released by: Nasdaq.com and their article: “We Did The Math IETC Can Go To $27 – Nasdaq” published on December 28, 2018 as well as Gurufocus.com‘s news article titled: “Thoughts on 2018 Performance – GuruFocus.com” with publication date: January 08, 2019.

Brown Capital Management Llc, which manages about $7.02B and $11.01 billion US Long portfolio, decreased its stake in Neogen Corp (NASDAQ:NEOG) by 34,141 shares to 6.36M shares, valued at $455.15M in 2018Q3, according to the filing. It also reduced its holding in Paycom Software Inc (NYSE:PAYC) by 312,663 shares in the quarter, leaving it with 4.00M shares, and cut its stake in Proto Labs Inc (NYSE:PRLB).

Among 21 analysts covering Cognex Corporation (NASDAQ:CGNX), 9 have Buy rating, 3 Sell and 9 Hold. Therefore 43% are positive. Cognex Corporation had 53 analyst reports since August 4, 2015 according to SRatingsIntel. Needham maintained Cognex Corporation (NASDAQ:CGNX) on Tuesday, August 4 with “Buy” rating. Raymond James initiated the shares of CGNX in report on Friday, January 22 with “Outperform” rating. The firm has “Buy” rating by Cowen & Co given on Wednesday, August 2. The firm has “Buy” rating by Cowen & Co given on Tuesday, February 13. The stock of Cognex Corporation (NASDAQ:CGNX) earned “Sell” rating by J.P. Morgan on Monday, May 7. The firm has “Underperform” rating given on Tuesday, August 2 by CLSA. Deutsche Bank initiated Cognex Corporation (NASDAQ:CGNX) on Thursday, December 8 with “Buy” rating. Northcoast downgraded the stock to “Neutral” rating in Friday, December 2 report. As per Thursday, October 11, the company rating was maintained by Morgan Stanley. Northcoast upgraded the stock to “Buy” rating in Wednesday, April 4 report.

Since September 11, 2018, it had 0 insider purchases, and 3 selling transactions for $1.38 million activity. $560,381 worth of stock was sold by SUN ANTHONY on Thursday, September 13.

Investors sentiment increased to 1.15 in Q3 2018. Its up 0.03, from 1.12 in 2018Q2. It is positive, as 28 investors sold CGNX shares while 106 reduced holdings. 49 funds opened positions while 105 raised stakes. 148.14 million shares or 0.09% more from 148.01 million shares in 2018Q2 were reported. Lazard Asset Management Limited Company has 1.26 million shares for 0.13% of their portfolio. Oppenheimer Asset Mngmt, a New York-based fund reported 74,234 shares. Goldman Sachs invested in 1.79 million shares. Manufacturers Life Insur The reported 295,668 shares. Wellington Mngmt Grp Inc Ltd Liability Partnership holds 1.09M shares or 0.01% of its portfolio. Tiaa Cref Management Limited Com reported 635,449 shares. Washington-based Parametric Port Associates Limited Co has invested 0.01% in Cognex Corporation (NASDAQ:CGNX). Employees Retirement System Of Texas accumulated 121,000 shares. Teacher Retirement System Of Texas holds 0.01% in Cognex Corporation (NASDAQ:CGNX) or 20,373 shares. New York-based Jefferies Grp Ltd Com has invested 0% in Cognex Corporation (NASDAQ:CGNX). Iberiabank holds 0.06% or 8,742 shares. Amundi Pioneer Asset Management Inc has 0.01% invested in Cognex Corporation (NASDAQ:CGNX) for 88,179 shares. Liberty Mutual Group Asset Mgmt Incorporated reported 34,440 shares. Vanguard Gru holds 0.03% or 14.77M shares. Hsbc Public Limited Company has invested 0% in Cognex Corporation (NASDAQ:CGNX).

Sage Therapeutics, Inc. (NASDAQ:SAGE) Institutional Positions Chart